• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结节病患者继发的致命性肺空洞性疾病。 (你提供的原文“secondary to in a patient with sarcoidosis”中“secondary to”后面似乎缺失了内容)

Fatal pulmonary cavitary disease secondary to in a patient with sarcoidosis.

作者信息

Abdulfattah Omar, Salhan Divya, Kandel Saroj, Rahman Ebad Ur, Dahal Sumit, Alnafoosi Zainab, Schmidt Frances

机构信息

Pulmonary and Critical Care Department, Interfaith Medical Center, Brooklyn, NY, USA.

Internal Medicine Department, Interfaith Medical Center, Brooklyn, NY, USA.

出版信息

J Community Hosp Intern Med Perspect. 2017 Dec 14;7(6):372-377. doi: 10.1080/20009666.2017.1407211. eCollection 2017.

DOI:10.1080/20009666.2017.1407211
PMID:29296252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5738639/
Abstract

: () has low pathogenicity and usually requires either host immune impairment or structural lung disease to cause clinical disease. Fatal cavitary infection in a patient without immunosuppression is rarely presented. : A 62-year-old female with history of sarcoidosis and hypertension presented with cough, fever and dyspnea for one week. Chest imaging showed irregular opacification of upper lung zones. The sputum samples tested positive for acid-fast bacilli (AFB) and the subsequent testing identified . She was started on rifampin, isoniazid, pyrazinamide and ethambutol along with azithromycin, and was discharged with plans to continue the same. A follow up sputum test was negative for AFB. She was, however, readmitted ten months later with sepsis due to pneumonia. Chest imaging revealed worsening cavitary lung lesions. Despite starting her on intravenous antibiotics while continuing anti-tubercular therapy, she developed severe respiratory distress and had to be intubated. Her condition continued to deteriorate and she expired the following day. Fatal cavitary infections with M. xenopi have been reported in the absence of established optimal management. Well-designed studies with sufficient power are needed to establish new treatment guidelines.

摘要

(某病原体)致病性较低,通常需要宿主免疫功能受损或存在结构性肺部疾病才会引发临床疾病。在没有免疫抑制的患者中很少出现致命的空洞性感染。:一名62岁女性,有结节病和高血压病史,出现咳嗽、发热和呼吸困难一周。胸部影像学显示上肺区不规则混浊。痰标本抗酸杆菌(AFB)检测呈阳性,随后的检测确定了(具体病原体)。她开始接受利福平、异烟肼、吡嗪酰胺和乙胺丁醇治疗,同时加用阿奇霉素,出院时计划继续相同治疗方案。后续痰检AFB呈阴性。然而,十个月后她因肺炎并发败血症再次入院。胸部影像学显示空洞性肺部病变恶化。尽管在继续抗结核治疗的同时开始给予静脉抗生素治疗,但她仍出现严重呼吸窘迫,不得不插管。她的病情继续恶化,第二天死亡。在缺乏既定最佳治疗方案的情况下,已报告了偶发分枝杆菌致命的空洞性感染。需要进行有足够效力的精心设计研究来制定新的治疗指南。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f682/5738639/737ac7264d2e/ZJCH_A_1407211_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f682/5738639/3299764d511a/ZJCH_A_1407211_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f682/5738639/ddcc7799d928/ZJCH_A_1407211_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f682/5738639/737ac7264d2e/ZJCH_A_1407211_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f682/5738639/3299764d511a/ZJCH_A_1407211_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f682/5738639/ddcc7799d928/ZJCH_A_1407211_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f682/5738639/737ac7264d2e/ZJCH_A_1407211_F0003_OC.jpg

相似文献

1
Fatal pulmonary cavitary disease secondary to in a patient with sarcoidosis.结节病患者继发的致命性肺空洞性疾病。 (你提供的原文“secondary to in a patient with sarcoidosis”中“secondary to”后面似乎缺失了内容)
J Community Hosp Intern Med Perspect. 2017 Dec 14;7(6):372-377. doi: 10.1080/20009666.2017.1407211. eCollection 2017.
2
Pulmonary Cavitary Disease Secondary to Mycobacterium xenopi Complicated by Respiratory Failure.继发于偶发分枝杆菌的肺空洞性疾病并发性呼吸衰竭
Cureus. 2018 Oct 29;10(10):e3512. doi: 10.7759/cureus.3512.
3
Navigating a Complex Case of in a Patient with Blue Rubber Bleb Nevus Syndrome.诊治蓝色橡皮疱痣综合征患者的复杂病例
Eur J Case Rep Intern Med. 2024 May 2;11(6):004530. doi: 10.12890/2024_004530. eCollection 2024.
4
Mycobacterium xenopi infection masquerading as pulmonary tuberculosis in two patients infected with the human immunodeficiency virus.两例人类免疫缺陷病毒感染者中,偶发分枝杆菌感染伪装成肺结核。
Clin Infect Dis. 1995 May;20(5):1399-401. doi: 10.1093/clinids/20.5.1399.
5
[Mycobacterium xenopi lung infection in a patient with multiple lung cysts that responded well to chemotherapy: a case report].[一名患有多个肺囊肿的患者发生偶发分枝杆菌肺部感染,化疗反应良好:病例报告]
Kekkaku. 2012 Nov;87(11):733-6.
6
[Two cases of pulmonary Mycobacterium xenopi infection].两例肺部偶发分枝杆菌感染
Nihon Kokyuki Gakkai Zasshi. 2003 Aug;41(8):556-60.
7
Pulmonary cavitary disease due to .由……引起的肺空洞性疾病。
Infect Med (Beijing). 2022 Jan 1;1(1):63-66. doi: 10.1016/j.imj.2021.11.001. eCollection 2022 Mar.
8
Pulmonary disease caused by Mycobacterium xenopi: the first case in Korea.由偶发分枝杆菌引起的肺部疾病:韩国首例病例。
Yonsei Med J. 2007 Oct 31;48(5):871-5. doi: 10.3349/ymj.2007.48.5.871.
9
Pulmonary disease due to Mycobacterium xenopi in a renal allograft recipient: report of a case and review.
Rev Infect Dis. 1989 Nov-Dec;11(6):964-9. doi: 10.1093/clinids/11.6.964.
10
Miliary pulmonary nodules due to Mycobacterium xenopi in a steroid-induced immunocompromised patient successfully treated with chemotherapy: a case report.类固醇诱导免疫功能低下患者因偶然分枝杆菌引起的粟粒性肺结节经化疗成功治疗:一例报告
BMC Pulm Med. 2016 Jun 10;16(1):92. doi: 10.1186/s12890-016-0252-y.

引用本文的文献

1
Dust to Disease: Cavitary Lung Lesion With in a Black Lung Patient.尘致疾病:一名煤工尘肺患者的空洞性肺部病变
J Investig Med High Impact Case Rep. 2025 Jan-Dec;13:23247096251348906. doi: 10.1177/23247096251348906. Epub 2025 Jun 25.
2
Long-term Findings in Bullous Sarcoidosis: A Case Report and Literature Review.大疱性结节病的长期观察结果:病例报告和文献复习。
Intern Med. 2023 Aug 15;62(16):2395-2400. doi: 10.2169/internalmedicine.1130-22. Epub 2022 Dec 21.
3
Pulmonary Cavitary Disease Secondary to Mycobacterium xenopi Complicated by Respiratory Failure.

本文引用的文献

1
Microbiological and Clinical Outcomes of Treating Non-Mycobacterium Avium Complex Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Review and Meta-Analysis.治疗非结核分枝杆菌肺病的微生物学和临床结局:系统评价和荟萃分析。
Chest. 2017 Jul;152(1):120-142. doi: 10.1016/j.chest.2017.04.166. Epub 2017 Apr 28.
2
Comparison of the spectrum of radiologic and clinical manifestations of pulmonary disease caused by Mycobacterium avium complex and Mycobacterium xenopi.比较鸟分枝杆菌复合群和胞内分枝杆菌引起的肺部疾病的放射学和临床表现的光谱。
Can Assoc Radiol J. 2014 Aug;65(3):207-13. doi: 10.1016/j.carj.2013.05.006. Epub 2013 Dec 8.
3
继发于偶发分枝杆菌的肺空洞性疾病并发性呼吸衰竭
Cureus. 2018 Oct 29;10(10):e3512. doi: 10.7759/cureus.3512.
Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.
非结核分枝杆菌感染的抗菌药物敏感性试验、耐药机制及治疗。
Clin Microbiol Rev. 2012 Jul;25(3):545-82. doi: 10.1128/CMR.05030-11.
4
Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.非结核分枝杆菌的耐药机制与药敏试验。
Drug Resist Updat. 2012 Jun;15(3):149-61. doi: 10.1016/j.drup.2012.04.001. Epub 2012 Apr 21.
5
Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France.偶发分枝杆菌肺部感染:法国东北部136例病例的多中心回顾性研究
Thorax. 2009 Apr;64(4):291-6. doi: 10.1136/thx.2008.096842. Epub 2008 Dec 3.
6
Mycobacterium xenopi clinical relevance and determinants, the Netherlands.偶发分枝杆菌的临床相关性及决定因素,荷兰
Emerg Infect Dis. 2008 Mar;14(3):385-9. doi: 10.3201/eid1403.061393.
7
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy.克拉霉素与环丙沙星作为利福平及乙胺丁醇治疗机会性分枝杆菌肺病的辅助用药及母牛分枝杆菌免疫疗法评估
Thorax. 2008 Jul;63(7):627-34. doi: 10.1136/thx.2007.087999. Epub 2008 Feb 4.
8
Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment.HIV阴性患者中偶发分枝杆菌引起的肺部疾病:接受标准化治疗患者的五年随访
Respir Med. 2003 Apr;97(4):439-44. doi: 10.1053/rmed.2002.1444.
9
Pulmonary resection for Mycobacterium xenopi pulmonary infection.对偶发分枝杆菌肺部感染进行肺切除术。
Ann Thorac Surg. 2001 Dec;72(6):1877-82. doi: 10.1016/s0003-4975(01)03245-3.
10
Mycobacterium xenopi arthritis.
J Rheumatol. 1998 May;25(5):1016-8.